Quarterly report pursuant to Section 13 or 15(d)

Acquisition of Patents and Intangibles - Purchase price allocation (Details)

v3.21.1
Acquisition of Patents and Intangibles - Purchase price allocation (Details) - Intangible Assets Obtained From ProstaGene L L C [Member]
$ in Thousands
Nov. 16, 2018
USD ($)
Acquired Finite-Lived Intangible Assets [Line Items]  
Equity issued $ 11,558
Acquisition costs 741
Release of deferred tax asset 2,827
Intangible assets acquired 15,126
Other costs 0
Total cost of acquisition $ 15,126